President, R&D & CMO
Mon, Feb 2, 2026
Feb 2
600 shares @ $44.20
Decreased holdings by -4.00%
Net across this filing: 0.00% (+0 shares)
30th largest trade (out of 50)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 97% above 200-day moving average